ProfileGDS4814 / ILMN_1678423
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 89% 92% 92% 90% 91% 92% 93% 91% 90% 93% 91% 90% 90% 92% 91% 90% 91% 91% 91% 91% 92% 91% 91% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)368.93689
GSM780708Untreated after 4 days (C2_1)528.72592
GSM780709Untreated after 4 days (C3_1)547.53592
GSM780719Untreated after 4 days (C1_2)404.44590
GSM780720Untreated after 4 days (C2_2)471.29591
GSM780721Untreated after 4 days (C3_2)561.36492
GSM780710Trastuzumab treated after 4 days (T1_1)585.50393
GSM780711Trastuzumab treated after 4 days (T2_1)480.68991
GSM780712Trastuzumab treated after 4 days (T3_1)387.91690
GSM780722Trastuzumab treated after 4 days (T1_2)617.02593
GSM780723Trastuzumab treated after 4 days (T2_2)465.78591
GSM780724Trastuzumab treated after 4 days (T3_2)398.09590
GSM780713Pertuzumab treated after 4 days (P1_1)407.99390
GSM780714Pertuzumab treated after 4 days (P2_1)504.80292
GSM780715Pertuzumab treated after 4 days (P3_1)434.54191
GSM780725Pertuzumab treated after 4 days (P1_2)422.00190
GSM780726Pertuzumab treated after 4 days (P2_2)490.56991
GSM780727Pertuzumab treated after 4 days (P3_2)457.61491
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)456.60291
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)456.71291
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)543.25892
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)459.70891
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)478.19691